HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is blockade of vascular endothelial growth factor beneficial for all types of diabetic retinopathy?

AuthorsD N Sang, P A D'Amore
JournalDiabetologia (Diabetologia) Vol. 51 Issue 9 Pg. 1570-3 (Sep 2008) ISSN: 0012-186X [Print] Germany
PMID18607560 (Publication Type: Comment, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Ranibizumab
Topics
  • Antibodies, Monoclonal (adverse effects, therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Diabetic Retinopathy (prevention & control)
  • Humans
  • Macular Degeneration (prevention & control)
  • Ranibizumab
  • Vascular Endothelial Growth Factor A (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: